Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 16/04/19971 min de lecture
Genzyme Corp.; Premarket Approval of SeprafilmSUPTM Bioresorbable Membrane
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is announcing its approval of the application by Genzyme Corp., Cambridge, MA, for premarket approval, under the Federal Food, Drug, and Cosmetic Act (the act), of Seprafilm TM Bioresorbable Membrane. After reviewing the recommendation of the General and Plastic Surgery Devices Panel, FDA's Center for Devices and Radiological Health (CDRH) notified the applicant, by letter of August 12, 1996, of the approval of the application.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →